Literature DB >> 7079921

Clinical experience with malignant pheochromocytomas.

H W Scott, V Reynolds, N Green, D Page, J A Oates, D Robertson, S Roberts.   

Abstract

In a 30 year period at Vanderbilt University Hospital, the affiliated Nashville General Hospital and the Nashville Veterans Administration Hospital, 64 patients with pheochromocytoma have been observed. In eight of these, the tumor proved to be malignant. Retrospective review of biologic characteristics of pheochromocytomas in this series included clinical, diagnostic imaging, chemical and histopathologic data. Aside from presence of distant metastases, none of these features had predictive value in indicating the biologic malignant nature of the primary tumor. One patient has been cured by radical surgical resection for 16 years. Three others have died with metastatic tumor and three patients are alive with metastatic tumor.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7079921

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  14 in total

1.  Clinical experience over 48 years with pheochromocytoma.

Authors:  R E Goldstein; J A O'Neill; G W Holcomb; W M Morgan; W W Neblett; J A Oates; N Brown; J Nadeau; B Smith; D L Page; N N Abumrad; H W Scott
Journal:  Ann Surg       Date:  1999-06       Impact factor: 12.969

2.  A logistic regression model for predicting malignant pheochromocytomas.

Authors:  Baohua Gao; Yanxia Sun; Zhongguo Liu; Fanwei Meng; Benkang Shi; Yuqiang Liu; Zhishun Xu
Journal:  J Cancer Res Clin Oncol       Date:  2007-11-13       Impact factor: 4.553

3.  Case report of metastatic familial pheochromocytoma treated with cisplatin and 5-fluorouracil.

Authors:  V Srimuninnimit; G L Wampler
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

4.  Flank pain after minor trauma as the initial manifestation of malignant pheochromocytoma; a case report.

Authors:  Hassan Niroomand; Atoosa Bagheri-Behzad; Eghlim Nemati; Mehrdad Taghipour; Mohsen Motalebi
Journal:  J Nephropharmacol       Date:  2015-06-26

5.  Immunocytochemical differential diagnosis of adrenocortical neoplasms using the monoclonal antibody D11.

Authors:  S Schröder; A Niendorf; E Achilles; M Dietel; B C Padberg; U Beisiegel; H Dralle; M Bressel; G Klöppel
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

6.  Spectrum of pheochromocytoma in the 131I-MIBG era.

Authors:  P S Cheung; N W Thompson; C F Dmuchowski; J C Sisson
Journal:  World J Surg       Date:  1988-08       Impact factor: 3.352

Review 7.  A case of pheochromocytoma with severe paralytic ileus.

Authors:  M Noguchi; T Taniya; K Ueno; M Yagi; R Izumi; K Konishi; I Miyazaki
Journal:  Jpn J Surg       Date:  1990-07

Review 8.  The treatment of malignant pheochromocytoma with iodine-131 metaiodobenzylguanidine (131I-MIBG): a comprehensive review of 116 reported patients.

Authors:  K C Loh; P A Fitzgerald; K K Matthay; P P Yeo; D C Price
Journal:  J Endocrinol Invest       Date:  1997-12       Impact factor: 4.256

9.  High incidence of malignant pheochromocytoma in a surgical unit. 26 cases out of 100 patients operated from 1971 to 1991.

Authors:  C Proye; M Vix; A Goropoulos; P Kerlo; M Lecomte-Houcke
Journal:  J Endocrinol Invest       Date:  1992-10       Impact factor: 4.256

Review 10.  Malignancies of the endocrine glands.

Authors:  F Linder; H Schnidt-Gayk; G E Feurle
Journal:  Jpn J Surg       Date:  1983-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.